Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate
![PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients](https://www.researchgate.net/publication/358432211/figure/fig2/AS:1121209584488532@1644328604530/ROC-curves-for-the-nadir-PSA-a-time-to-nadir-PSA-b-PSA-doubling-time-c-PSA_Q320.jpg)
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image5.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image15.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
![Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2490-14-49/MediaObjects/12894_2013_Article_339_Fig2_HTML.jpg)
Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text
![Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology](https://www.auajournals.org/cms/asset/57cd23a1-cfd8-4e19-80b1-1d21ce7d2fb6/juro.2020.203.issue-6.cover.jpg)
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology
![Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/cb3c06b7-d646-416d-bfe7-c647f52d8387/bju15724-fig-0001-m.jpg)
Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library
![Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/36f368ac-c7b1-4b20-9b5d-f7b2866b3819/bju15724-fig-0002-m.jpg)
Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library
CUAJ – Review Danielson et al Management of non-metastatic prostate cancer Management algorithms for prostate-specific antigen
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image1.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![IJTM | Free Full-Text | Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study IJTM | Free Full-Text | Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study](https://www.mdpi.com/ijtm/ijtm-02-00047/article_deploy/html/images/ijtm-02-00047-g001.png)
IJTM | Free Full-Text | Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study
![IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/8/e002903/F5.large.jpg)
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
![Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-20319-z/MediaObjects/41598_2022_20319_Fig1_HTML.png)